| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.31 | 0.3 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.29 | 0.08 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |